Rockwell Collins to Sell Kaiser Optical Systems to Endress+Hauser - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rockwell Collins to Sell Kaiser Optical Systems to Endress+Hauser



Rockwell Collins announced that it has agreed to sell its subsidiary, Kaiser Optical Systems, a spectrographic instrumentation and applied holographic technology company, to Endress+Hauser, a producer of measurement instrumentation and services for industrial process engineering. Terms of the agreement were not disclosed. The sale is expected to be complete in early fiscal 2014 and is subject to customary closing conditions.

Kaiser Optical Systems, located in Ann Arbor, Michigan, became a Rockwell Collins company in 2000 as part of the company’s purchase of K Systems, the parent company of Kaiser Aerospace and Electronics. Principal products include Raman sensors and instrumentation, advanced holographic components for
spectroscopy, telecommunications, astronomy and ultra-fast sciences, and components for aircraft display systems.

Source: Rockwell Collins

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here